CoviSafe “The project will integrate Orpheus' novel biologics platform, coupled with third party rapid detection and portable device technology, to develop a reliable palm-sized test for screening of COVID-19 virus in saliva. Orpheus and its academic collaborators have already spent over $500,000 on the development of a series of novel biologic-based detection reagents that are protected by existing intellectual property and know-how.”
So there is therma bright
Orpheus Medica
The “academic collaborators” are Carlos Escobedo and co from Queens University
https://mobile.twitter.com/Micro_Optofluid
And the third party is Deep Biologics https://mobile.twitter.com/DeepBiologics
All together they’re developing CoviSafe with federal government grants